As Genomics Revenues Fall 18 Percent, Roche Plans to Focus on Sequencing, qPCR, Custom Biotech | GenomeWeb

In a presentation outlining Roche's 2012 financial results for the first half of the year, the company shed further light on its previously disclosed plans to restructure its Applied Science business, noting that it intends to focus on sequencing, qPCR, and custom biotech services and reagents.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.